INFLIXIMAB AS THIRD-LINE THERAPY FOR DIFFICULT-TO-TREAT AUTOIMMUNE HEPATITIS

被引：0
|
作者：
Weiler-Normann, Christina [1 ]
Wiegard, Christiane C. [1 ]
Glaubke, Claudia [1 ]
Quaas, Alexander [2 ]
Schramm, Christoph [1 ]
Lahse, Ansgar W. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin 1, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1672
引用
收藏
页码：1118A / 1118A
页数：1
相关论文
共 50 条
  • [1] Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis
    Weiler-Normann, Christina
    Schramm, Christoph
    Quaas, Alexander
    Wiegard, Christiane
    Glaubke, Claudia
    Pannicke, Nadine
    Moeller, Sina
    Lohse, Ansgar W.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 529 - 534
  • [2] Tacrolimous in the Management of Difficult-to-Treat Autoimmune Hepatitis
    Hanouneh, Mohamad A.
    Garber, Ari
    Alsuleiman, Bayan
    Markus, Johnathon
    Barnes, David
    Carey, William
    McCullough, Arthur
    Lopez, Rocio
    Zein, Nizar N.
    Hanouneh, Ibrahim A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S882 - S882
  • [3] A Case of Difficult-to-Treat Autoimmune Hepatitis Successfully Managed by TNF-α Blockade
    Weiler-Normann, Christina
    Wiegard, Christiane
    Schramm, Christoph
    Lohse, Ansgar Wilhelm
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (11): : 2877 - 2878
  • [4] The Utility of Tacrolimus in the Management of Adults with Difficult-to-Treat Autoimmune Hepatitis: Review of Literature
    Ascha, Mustafa
    Hanouneh, Mohamad
    Zein, Nizar
    McCullough, Arthur
    Hanouneh, Ibrahim
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S385 - S385
  • [5] Treatment of hepatitis C in difficult-to-treat patients
    Peter Ferenci
    [J]. Nature Reviews Gastroenterology & Hepatology, 2015, 12 : 284 - 292
  • [6] Treatment of hepatitis C in difficult-to-treat patients
    Ferenci, Peter
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (05) : 284 - 292
  • [7] Treating hepatitis C in "difficult-to-treat" patients
    Pawlotsky, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 422 - 423
  • [8] Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
    Arvaniti, Pinelopi
    Giannoulis, George
    Gabeta, Stella
    Zachou, Kalliopi
    Koukoulis, George K.
    Dalekos, George N.
    [J]. JHEP REPORTS, 2020, 2 (04)
  • [9] Antiviral therapy for "difficult-to-treat" hepatitis C virus-infected patients
    Tatsuo Kanda
    Osamu Yokosuka
    Masao Omata
    [J]. 中华医学杂志(英文版), 2013, (23) : 4568 - 4574
  • [10] Optimizing dosage and duration therapy for chronic hepatitis C "difficult-to-treat patients"
    Ladero, Jose M.
    [J]. ANNALS OF HEPATOLOGY, 2008, 7 (04) : 392 - 394
12345